Dudediligence.

Aclaris Therapeutics, Inc

ACRSNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 2113GPassive stake of 5% or more (13G), filed by Frazier Life Sciences Public Fund
  2. Aug 68-KMaterial agreement1.019.01
  3. Aug 610-QQuarterly report
  4. Aug 68-KResults of operations2.029.01
  5. Jun 48-KShareholder vote5.07
  6. May 710-QQuarterly report
  7. May 78-KResults of operations2.029.01
  8. Apr 288-KRegulation FD disclosure and other events7.018.019.01
  9. Mar 118-KRegulation FD disclosure7.01
  10. Mar 108-KRegulation FD disclosure7.01
  11. Feb 2610-KAnnual report
  12. Feb 268-KResults of operations2.029.01
  13. Jan 128-KRegulation FD disclosure7.019.01
  14. Jan 68-KRegulation FD disclosure and other events7.018.019.01
  15. Nov 6, 202510-QQuarterly report
  16. Nov 6, 20258-KResults of operations2.029.01
  17. Oct 14, 20258-KRegulation FD disclosure7.019.01
  18. Aug 7, 202510-QQuarterly report
  19. Aug 7, 20258-KResults of operations2.029.01
  20. Jul 29, 20258-KRegulation FD disclosure and other events7.018.019.01
  21. Jun 30, 20258-KRegulation FD disclosure7.019.01
  22. Jun 5, 20258-KOfficer or director change and bylaws or fiscal year changed5.025.035.079.01
  23. May 8, 202510-QQuarterly report
  24. May 8, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  25. Feb 27, 2025S-3Shelf registration
  26. Feb 27, 202510-KAnnual report
  27. Feb 27, 20258-KResults of operations2.029.01
  28. Jan 13, 20258-KRegulation FD disclosure7.019.01
  29. Dec 31, 2024424B3Prospectus for an offering
  30. Dec 19, 2024S-3Shelf registration
  31. Nov 18, 20248-KMaterial agreement and unregistered sale of shares1.013.025.027.018.019.01
  32. Nov 6, 202410-QQuarterly report
  33. Nov 6, 20248-KResults of operations2.029.01